Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
61.304,24
0,83%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Silence Therapeutics PLC (SLN) Silence Therapeutics PLC (SLN) Notizie

Silence Therapeutics PLC

SLN
21,21
-1,74 (-7,58%)
11 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/5/202423:14EDGAR2Form DEL AM - Delaying amendment
30/4/202414:30BWSilence Therapeutics to Participate in Fireside Chat at H.C...
29/4/202414:30BWSilence Therapeutics Announces Retirement of Alistair Gray..
08/4/202417:48BWSilence Therapeutics Announces JAMA Publication of..
13/3/202412:05BWSilence Therapeutics Reports Full Year 2023 Financial..
13/3/202412:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
13/3/202412:00BWSilence Therapeutics Announces Positive Topline 36-Week Data..
28/2/202414:00BWSilence Therapeutics to Report Fourth Quarter and Full Year..
23/2/202414:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/2/202414:00BWSilence Therapeutics Achieves $10 Million Milestone Payment..
14/2/202415:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202414:00BWSilence Therapeutics Announces Oversubscribed $120 Million..
31/1/202413:00BWSilence Therapeutics to Participate in Fireside Chat at..
01/12/202313:00BWSilence Therapeutics Strengthens Executive Leadership Team..
14/11/202313:00BWSilence Therapeutics Highlights Recent Company Progress and..
08/11/202313:00BWSilence Therapeutics to Present at Jefferies London..
01/11/202312:00BWSilence Therapeutics Announces Positive Topline Results from..
26/9/202313:00BWSilence Therapeutics to Participate in Fireside Chat at..
06/9/202313:00BWSilence Therapeutics to Participate in September Investor..
29/8/202322:01EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
16/8/202313:00BWSilence Therapeutics Reports Second Quarter 2023 Results
01/8/202322:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/7/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/7/202313:00BWSilence Therapeutics Achieves $4 Million in Research..
31/5/202313:00BWSilence Therapeutics to Present at the Jefferies Healthcare..
16/5/202322:00BWSilence Therapeutics Reports First Quarter 2023 Results
Apertura: 22,84 Min: 21,23 Max: 23,09
Chiusura: 22,95

La tua Cronologia

NASDAQ
SLN
Silence Therapeutics
GDAX
LINKBTC
ChainLink Token
NYSE
NETC
Nabors Energy Transition
NYSE
FTCH
Farfetch
LSE
BRTU
Ubs Etc Brent U
NASDAQ
CLSM
Cabana Target Leading Se...
TSX
EFN.PR.C
Element Fleet Management
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network